Related Experiment Video
Updated: Jun 2, 2026

07:01
Direct Mouse Trauma/Burn Model of Heterotopic Ossification
Published on: August 6, 2015
Heterotopic ossification after primary total ankle arthroplasty.
Keun-Bae Lee1, Yong-Jin Cho, Ju-Kwon Park
1Department of Orthopaedic Surgery, Chonnam National University Medical School and Hospital, 8 Hakdong, Donggu, Gwangju, 501-757, South Korea. kbleeos@chonnam.ac.kr
The Journal of Bone and Joint Surgery. American Volume
|April 22, 2011
Summary
Heterotopic ossification (HO) occurs in 25% of total ankle arthroplasty patients, often posteriorly. This condition significantly impacts ankle motion and clinical outcomes, necessitating preventative strategies.
Area of Science:
- Orthopedic Surgery
- Biomedical Engineering
Background:
- Heterotopic ossification (HO) is a known complication following lower-limb joint arthroplasty.
- No prior comprehensive studies have specifically investigated HO after total ankle arthroplasty (TAA).
Purpose of the Study:
- To determine the prevalence and location of HO after primary TAA.
- To identify predisposing factors for HO development.
- To assess the impact of HO on clinical outcomes and establish a classification system.
Main Methods:
- Prospective follow-up of 80 patients (80 ankles) undergoing primary TAA.
- Mean follow-up duration of 31.9 months.
- Analysis of HO prevalence, location, predisposing factors, clinical outcomes, and development of a classification system.
Main Results:
- Twenty percent (25%) of ankles developed postoperative HO, predominantly in the posterior aspect.
- HO was classified into four grades (I-IV).
- Symptomatic HO occurred in 10% of patients, with two requiring surgical resection.
- Ankles with HO showed longer operative times, reduced motion, and lower AOFAS scores at follow-up.
Conclusions:
- HO is a considerable complication after primary TAA, affecting 25% of patients.
- HO is associated with decreased ankle motion and poorer clinical outcomes at two years.
- Strategies to minimize HO occurrence are crucial in TAA procedures.
